ArticleJournal of cancer immunology2024

A Paradoxical AKT: Exploring the Promise and Challenges of PI3K/AKT/mTOR Targeted Therapies.

Gennie L Parkman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.